Citadel Advisors »

Stoke Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $90k 17k 5.26
2023-09-30 $322k 82k 3.94
2023-06-30 $2.1M 195k 10.63
2023-03-31 $2.0M 238k 8.33
2022-12-31 $3.0M 329k 9.23
2022-06-30 $1.7M 125k 13.21
2022-03-31 $2.7M 129k 21.06
2021-12-31 $202k 8.4k 23.99
2021-09-30 $1.1M 43k 25.44
2021-06-30 $2.9M 87k 33.70
2021-03-31 $1.7M 45k 38.88
2020-12-31 $1.2M 19k 61.92
2020-09-30 $482k 14k 33.47
2020-03-31 $432k 19k 22.91
2019-12-31 $296k 11k 28.27
2019-06-30 $2.9M 100k 29.16